Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin J Anstrom

Showing results (81-90 of 328) with videos related to

Pageof 33
Sort By:
Journal of Clinical Microbiology|January 5, 2007
Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agentsBarbara D Alexander, Terry C Byrne, Kelly L Smith, et al.
The American Journal of Medicine|February 3, 2009
Do income level and race influence survival in patients receiving hemodialysis?Eric L Eisenstein, Jie L Sun, Kevin J Anstrom, et al.
Journal of the American Academy of Dermatology|November 16, 2010
Central hair loss in African American women: incidence and potential risk factorsElise A Olsen, Valerie Callender, Amy McMichael, et al.
Circulation. Heart Failure|May 4, 2016
Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart FailureGregory D Lewis, Marc J Semigran, Michael M Givertz, et al.
Journal of Cardiovascular Electrophysiology|February 6, 2010
Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysisJonathan P Piccini, Sana M Al-Khatib, Evan R Myers, et al.
JACC. Clinical Electrophysiology|May 25, 2019
Patient-Reported Outcomes in Atrial Fibrillation Research: Results of a Clinicaltrials.gov AnalysisBenjamin A Steinberg, Paul Dorian, Kevin J Anstrom, et al.
JACC. Cardiovascular Interventions|February 5, 2010
Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)Eric L Eisenstein, Martin B Leon, David E Kandzari, et al.
The American Journal of Medicine|June 13, 2025
Extended Thromboprophylaxis in Patients Hospitalized with COVID-19 at Time of Discharge is Not Associated with Improvement in Quality of LifeLana Wahid, Taeim Kwon, Lisa Baumann Kreuziger, et al.
The American Journal of Cardiology|November 7, 2016
Implications of Serum Chloride Homeostasis in Acute Heart Failure (from ROSE-AHF)Justin L Grodin, Jie-Lena Sun, Kevin J Anstrom, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Using Artificial Intelligence to Assess Treatment-Effect Heterogeneity in Pragmatic Cardiovascular Trials: Insights from TRANSFORM-HFGuangyu Tong, Changjun Li, Fan Li, et al.
Pageof 33

Showing results (81-90 of 328) with videos related to

Sort By:
Pageof 33
Journal of Clinical Microbiology|January 5, 2007
Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agentsBarbara D Alexander, Terry C Byrne, Kelly L Smith, et al.
The American Journal of Medicine|February 3, 2009
Do income level and race influence survival in patients receiving hemodialysis?Eric L Eisenstein, Jie L Sun, Kevin J Anstrom, et al.
Journal of the American Academy of Dermatology|November 16, 2010
Central hair loss in African American women: incidence and potential risk factorsElise A Olsen, Valerie Callender, Amy McMichael, et al.
Circulation. Heart Failure|May 4, 2016
Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart FailureGregory D Lewis, Marc J Semigran, Michael M Givertz, et al.
Journal of Cardiovascular Electrophysiology|February 6, 2010
Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysisJonathan P Piccini, Sana M Al-Khatib, Evan R Myers, et al.
JACC. Clinical Electrophysiology|May 25, 2019
Patient-Reported Outcomes in Atrial Fibrillation Research: Results of a Clinicaltrials.gov AnalysisBenjamin A Steinberg, Paul Dorian, Kevin J Anstrom, et al.
JACC. Cardiovascular Interventions|February 5, 2010
Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)Eric L Eisenstein, Martin B Leon, David E Kandzari, et al.
The American Journal of Medicine|June 13, 2025
Extended Thromboprophylaxis in Patients Hospitalized with COVID-19 at Time of Discharge is Not Associated with Improvement in Quality of LifeLana Wahid, Taeim Kwon, Lisa Baumann Kreuziger, et al.
The American Journal of Cardiology|November 7, 2016
Implications of Serum Chloride Homeostasis in Acute Heart Failure (from ROSE-AHF)Justin L Grodin, Jie-Lena Sun, Kevin J Anstrom, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Using Artificial Intelligence to Assess Treatment-Effect Heterogeneity in Pragmatic Cardiovascular Trials: Insights from TRANSFORM-HFGuangyu Tong, Changjun Li, Fan Li, et al.
Pageof 33